Patent search ap:("THE REGENTS OF THE UNIVERSITY OF MICHIGAN") AND inv:"Changwei Wang" Page 1

1.

发明授权
Imidazopyrimidines as EED inhibitors and the use thereof 有权

公开(公告)号：US12145944B2

公开(公告)日：2024-11-19

申请号：US16971472

申请日：2020-07-16

Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN

Inventor： Shaomeng Wang , Rohan Rej , Changwei Wang , Mi Wang , Jianfeng Lu , Chao-Yie Yang , Ester Fernandez-Salas , Jeanne Stuckey

IPC: A61K31/277 , A61K45/06 , A61P35/00 , C07D471/22 , C07D487/04 , C07D487/14 , C07D491/22 , C07D495/14 , C07D495/22 , C07D498/22 , C07D513/22 , C07F9/6561

Abstract: The present disclosure provides compounds represented by Formula I: wherein R1, R2, R3, and R4 are as defined in the specification, and the salts and solvates thereof. Compounds of Formula I are EED inhibitors. EED inhibitors are useful for the treatment of cancer and other diseases.

2.

发明申请
IMIDAZOPYRIMIDINES AS EED INHIBITORS AND THE USE THEREOF 有权

公开(公告)号：US20250034162A1

公开(公告)日：2025-01-30

申请号：US18887703

申请日：2024-09-17

Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN

Inventor： Shaomeng Wang , Rohan Rej , Changwei Wang , Mi Wang , Jianfeng Lu , Chao-Yie Yang , Ester Fernandez-Salas , Jeanne Stuckey

IPC: C07D491/22 , A61K45/06 , A61P35/00 , C07D471/22 , C07D487/04 , C07D487/14 , C07D495/14 , C07D495/22 , C07D498/22 , C07D513/22 , C07F9/6561

Abstract: The present disclosure provides compounds represented by Formula I: wherein R1, R2, R3, and R4 are as defined in the specification, and the salts and solvates thereof. Compounds of Formula I are EED inhibitors. EED inhibitors are useful for the treatment of cancer and other diseases.

3.

发明申请
IMIDAZOPYRIMIDINES AS EED INHIBITORS AND THE USE THEREOF 有权

公开(公告)号：US20220227778A1

公开(公告)日：2022-07-21

申请号：US16971472

申请日：2020-07-16

Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN

Inventor： Shaomeng Wang , Rohan Rej , Changwei Wang , Mi Wang , Jianfeng Lu , Chao-Yie Yang , Ester Fernandez-Salas , Jeanne Stuckey

IPC: C07D491/22 , C07D487/14 , C07D471/22 , C07D495/14 , C07D495/22 , C07D513/22 , C07D487/04 , C07F9/6561 , C07D498/22 , A61P35/00 , A61K45/06

Abstract: The present disclosure provides compounds represented by Formula I: wherein R1, R2, R3, and R4 are as defined in the specification, and the salts and solvates thereof. Compounds of Formula I are EED inhibitors. EED inhibitors are useful for the treatment of cancer and other diseases.

Patent Agency Ranking